{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:03Z","timestamp":1786119243109,"version":"build-2736575974"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,5]]},"DOI":"10.1097\/01.pra.0000351883.75754.45","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T15:19:19Z","timestamp":1242919159000},"page":"221-226","source":"Crossref","is-referenced-by-count":6,"title":["Aripiprazole in Treatment-refractory Schizophrenia"],"prefix":"10.1097","volume":"15","author":[{"given":"Wen-Yu","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-I","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan-Ying","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210210","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R2-9-20210210","first-page":"97","article-title":"The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling","volume":"24","author":"Overall","year":"1988","journal-title":"Psychopharmacol Bull"},{"key":"R4-9-20210210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","article-title":"Clozapine: a clinical review of adverse effects and management","volume":"15","author":"Iqbal","year":"2003","journal-title":"Ann Clin Psychiatry"},{"key":"R5-9-20210210","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-200022030-00004","article-title":"Tolerability of atypical antipsychotics","volume":"22","author":"Stanniland","year":"2000","journal-title":"Drug Safety"},{"key":"R6-9-20210210","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1192\/S0007125000296906","article-title":"Clozapine-associated agranulocytosis: risk and aetiology","volume":"17","author":"Krupp","year":"1992","journal-title":"Br J Psychiatry Suppl"},{"key":"R7-9-20210210","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1345\/aph.1G396","article-title":"Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring","volume":"40","author":"Schulte","year":"2006","journal-title":"Ann Pharmacother"},{"key":"R8-9-20210210","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/WNL.41.3.369","article-title":"Clozapine-related seizures","volume":"41","author":"Devinsky","year":"1991","journal-title":"Neurology"},{"key":"R9-9-20210210","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.4088\/JCP.v66n0905","article-title":"Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study","volume":"66","author":"Henderson","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"R10-9-20210210","first-page":"1717","article-title":"\u2018Awakening\u2019: a confusing improvement during treatment with atypical antipsychotic agents","volume":"149","author":"Vergouwen","year":"2005","journal-title":"Ned Tijdschr Geneeskd"},{"key":"R11-9-20210210","doi-asserted-by":"crossref","first-page":"674","DOI":"10.4088\/JCP.v67n0420c","article-title":"High-dose aripiprazole in treatment-resistant schizophrenia","volume":"67","author":"Duggal","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R12-9-20210210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1177\/0269881107083850","article-title":"Use of aripiprazole in treatment resistant schizophrenia","volume":"22","author":"Hughes","year":"2008","journal-title":"J Psychopharmacol"},{"key":"R13-9-20210210","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine","volume":"68","author":"Kane","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R14-9-20210210","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr Bull"},{"key":"R15-9-20210210","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1600-0447.2005.00612.x","article-title":"An exploratory open-label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia","volume":"113","author":"Henderson","year":"2006","journal-title":"Acta Psychiatr Scand"},{"key":"R16-9-20210210","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00044011-200626030-00001","article-title":"Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation","volume":"26","author":"Ziegenbein","year":"2006","journal-title":"Clin Drug Investig"},{"key":"R17-9-20210210","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pnpbp.2006.09.015","article-title":"Aripiprazole augmentation in the management of residual symptoms in clozapine-treated outpatients with chronic schizophrenia: an open-label pilot study","volume":"31","author":"Mitsonis","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"R18-9-20210210","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1080\/j.1440-1614.2005.01688_2.x","article-title":"Combination of clozapine and aripiprazole: a promising approach in treatment-resistant schizophrenia","volume":"39","author":"Ziegenbein","year":"2005","journal-title":"Aust N Z J Psychiatry"},{"key":"R19-9-20210210","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1592\/phco.27.11.1599","article-title":"Augmentation of aripiprazole with low-dose clozapine","volume":"27","author":"Stoner","year":"2007","journal-title":"Pharmacotherapy"},{"key":"R20-9-20210210","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1124\/jpet.105.092155","article-title":"Intrinsic efficacy of antipsychotics at human D2, D3, and D4 dopamine receptors: identification of the clozapine metabolite N-desmethylclozapine as a D2\/D3 partial agonist","volume":"315","author":"Burstein","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-9-20210210","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00213-004-1940-5","article-title":"The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine","volume":"177","author":"Weiner","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"R22-9-20210210","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/schbul\/sbm143","article-title":"Unanswered questions in schizophrenia clinical trials","volume":"34","author":"Kane","year":"2008","journal-title":"Schizophrenia Bull"},{"key":"R23-9-20210210","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-244X-5-26","article-title":"Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics","volume":"5","author":"Faries","year":"2005","journal-title":"BMC Psychiatry"},{"key":"R24-9-20210210","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00131746-200507000-00005","article-title":"Antipsychotic polypharmacy: is there evidence for its use?","volume":"11","author":"Patrick","year":"2005","journal-title":"J Psychiatr Pract"},{"key":"R25-9-20210210","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.pra.0000341890.05383.45","article-title":"Polypharmacy with secondgeneration antipsychotics: a review of evidence","volume":"14","author":"Pandurangi","year":"2008","journal-title":"J Psychiatr Pract"},{"key":"R26-9-20210210","first-page":"472.22","article-title":"Clozapine alone versus clozapine and risperidone with refractory schizophrenia","volume":"543","author":"Honer","year":"2006","journal-title":"NEMJ"},{"key":"R27-9-20210210","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4088\/JCP.v69n0505","article-title":"Aripiprazole augmentation in clozapine-treated patients with refractory schizophrenia: an 8-week, randomized, double-blind, placebo-controlled trial","volume":"69","author":"Chang","year":"2008","journal-title":"J Clin Psychiatry"},{"key":"R28-9-20210210","article-title":"Scale for the Assessment of Negative Symptoms (SANS)","author":"Andreasen","year":"1983"},{"key":"R29-9-20210210","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1176\/appi.ajp.158.9.1367","article-title":"The emerging role of glutamate in the pathophysiology and treatment of schizophrenia","volume":"158","author":"Goff","year":"2001","journal-title":"Am J Psychiatry"},{"key":"R30-9-20210210","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.schres.2009.01.002","article-title":"The efficacy of lamotrigine in clozapine-resistant schizophrenia: a systematic review and meta-analysis","volume":"109","author":"Tiihonen","year":"2009","journal-title":"Schizophr Res"}],"container-title":["Journal of Psychiatric Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00131746-200905000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:53:06Z","timestamp":1786038786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00131746-200905000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pra.0000351883.75754.45","relation":{},"ISSN":["1538-1145"],"issn-type":[{"value":"1538-1145","type":"print"}],"subject":[],"published":{"date-parts":[[2009,5]]}}}